Urinary System Drugs Market Report

China Urinary System Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 25, 2023
  • PAGES：137
  • REPORT CODE：GMM1813631
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Urinary System Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Lupin

    • Cipla

    • Merck

    • Astellas Pharma

    • Apogepha

    • Boehringer Ingelheim

    • AstraZeneca

    • Jiangsu Lianhuan Pharmaceutical

    • Johnson & Johnson

    • Abbott Laboratories

    • Novartis

    • Sun Pharma

    • Daiichi Sankyo

    • Eli Lilly

    • Tianjin Tongrentang Group

    • Kunming Jida Pharmaceutical

    • Bayer

    • Mylan

    • GSK

    • Jiangsu Hengrui Pharmaceutical

    • Kowa

    • Cubist Pharmaceuticals

    • Dr Dunner

    • Sanofi

    • Jiangxi Jimin Kexin Jinshuibao Pharmaceutical

    • Hunan Qianjin Xiang River Pharmaceutical

    • Melinta Therapeutics

    By Type:

    • Powder

    • Injection

    • Pills

    • Cream

    • Tablets

    • Capsule

    • Suppository

    • Others

    • Granules

    By Application:

    • Medication For Prostate Disease

    • Others

    • Male Dysfunction

    • Kidney Disease Medication

    • Lithotripsy Drug

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Urinary System Drugs Market Overview 2018-2029

    • 1.1 China Urinary System Drugs Industry Development Overview

    • 1.2 China Urinary System Drugs Industry Development History

    • 1.3 China Urinary System Drugs Industry Market Size (2018-2029)

    • 1.4 China Urinary System Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Powder (2018-2029)

      • 1.4.2 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

      • 1.4.3 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Pills (2018-2029)

      • 1.4.4 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Cream (2018-2029)

      • 1.4.5 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Tablets (2018-2029)

      • 1.4.6 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Capsule (2018-2029)

      • 1.4.7 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Suppository (2018-2029)

      • 1.4.8 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.9 China Urinary System Drugs Production Volume, Production Value and Growth Rate of Granules (2018-2029)

    • 1.5 China Urinary System Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Medication For Prostate Disease (2018-2029)

      • 1.5.2 China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Male Dysfunction (2018-2029)

      • 1.5.4 China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Kidney Disease Medication (2018-2029)

      • 1.5.5 China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Lithotripsy Drug (2018-2029)

    • 1.6 China Urinary System Drugs Market Analysis by Region

      • 1.6.1 North China Urinary System Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Urinary System Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Urinary System Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Urinary System Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Urinary System Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Urinary System Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Urinary System Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Urinary System Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Urinary System Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Urinary System Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Urinary System Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Urinary System Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Urinary System Drugs Industry Development

    Chapter 3 Urinary System DrugsIndustry Chain Analysis

    • 3.1 Urinary System Drugs Industry Chain

    • 3.2 Urinary System Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Urinary System Drugs Market

    • 3.3 Urinary System Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Urinary System Drugs Market

    Chapter 4 China Urinary System Drugs Market, by Type

    • 4.1 China Urinary System Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Urinary System Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Urinary System Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Urinary System Drugs Production Volume and Growth Rate of Powder

      • 4.5.2 China Urinary System Drugs Production Volume and Growth Rate of Injection

      • 4.5.3 China Urinary System Drugs Production Volume and Growth Rate of Pills

      • 4.5.4 China Urinary System Drugs Production Volume and Growth Rate of Cream

      • 4.5.5 China Urinary System Drugs Production Volume and Growth Rate of Tablets

      • 4.5.6 China Urinary System Drugs Production Volume and Growth Rate of Capsule

      • 4.5.7 China Urinary System Drugs Production Volume and Growth Rate of Suppository

      • 4.5.8 China Urinary System Drugs Production Volume and Growth Rate of Others

      • 4.5.9 China Urinary System Drugs Production Volume and Growth Rate of Granules

    Chapter 5 China Urinary System Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Urinary System Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Urinary System Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Urinary System Drugs Market Size and Growth Rate of Medication For Prostate Disease

      • 5.5.2 China Urinary System Drugs Market Size and Growth Rate of Others

      • 5.5.3 China Urinary System Drugs Market Size and Growth Rate of Male Dysfunction

      • 5.5.4 China Urinary System Drugs Market Size and Growth Rate of Kidney Disease Medication

      • 5.5.5 China Urinary System Drugs Market Size and Growth Rate of Lithotripsy Drug

    Chapter 6 China Urinary System Drugs Market, by Region

    • 6.1 China Urinary System Drugs Production Volume and Production Value, by Region

    • 6.2 China Urinary System Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Urinary System Drugs Market Analysis

    • 7.1 North China Urinary System Drugs Market, by Type

    • 7.2 North China Urinary System Drugs Market, by Application

    Chapter 8 Central China Urinary System Drugs Market Analysis

    • 8.1 Central China Urinary System Drugs Market, by Type

    • 8.2 Central China Urinary System Drugs Market, by Application

    Chapter 9 South China Urinary System Drugs Market Analysis

    • 9.1 South China Urinary System Drugs Market, by Type

    • 9.2 South China Urinary System Drugs Market, by Application

    Chapter 10 East China Urinary System Drugs Market Analysis

    • 10.1 East China Urinary System Drugs Market, by Type

    • 10.2 East China Urinary System Drugs Market, by Application

    Chapter 11 Northeast China Urinary System Drugs Market Analysis

    • 11.1 Northeast China Urinary System Drugs Market, by Type

    • 11.2 Northeast China Urinary System Drugs Market, by Application

    Chapter 12 Southwest China Urinary System Drugs Market Analysis

    • 12.1 Southwest China Urinary System Drugs Market, by Type

    • 12.2 Southwest China Urinary System Drugs Market, by Application

    Chapter 13 Northwest China Urinary System Drugs Market Analysis

    • 13.1 Northwest China Urinary System Drugs Market, by Type

    • 13.2 Northwest China Urinary System Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Lupin

        • 14.1.1 Lupin Company Profile

        • 14.1.2 Lupin Urinary System Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Cipla

        • 14.2.1 Cipla Company Profile

        • 14.2.2 Cipla Urinary System Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Merck

        • 14.3.1 Merck Company Profile

        • 14.3.2 Merck Urinary System Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Astellas Pharma

        • 14.4.1 Astellas Pharma Company Profile

        • 14.4.2 Astellas Pharma Urinary System Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Apogepha

        • 14.5.1 Apogepha Company Profile

        • 14.5.2 Apogepha Urinary System Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Boehringer Ingelheim

        • 14.6.1 Boehringer Ingelheim Company Profile

        • 14.6.2 Boehringer Ingelheim Urinary System Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AstraZeneca

        • 14.7.1 AstraZeneca Company Profile

        • 14.7.2 AstraZeneca Urinary System Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Jiangsu Lianhuan Pharmaceutical

        • 14.8.1 Jiangsu Lianhuan Pharmaceutical Company Profile

        • 14.8.2 Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Johnson & Johnson

        • 14.9.1 Johnson & Johnson Company Profile

        • 14.9.2 Johnson & Johnson Urinary System Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Abbott Laboratories

        • 14.10.1 Abbott Laboratories Company Profile

        • 14.10.2 Abbott Laboratories Urinary System Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Novartis

        • 14.11.1 Novartis Company Profile

        • 14.11.2 Novartis Urinary System Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Sun Pharma

        • 14.12.1 Sun Pharma Company Profile

        • 14.12.2 Sun Pharma Urinary System Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Daiichi Sankyo

        • 14.13.1 Daiichi Sankyo Company Profile

        • 14.13.2 Daiichi Sankyo Urinary System Drugs Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Eli Lilly

        • 14.14.1 Eli Lilly Company Profile

        • 14.14.2 Eli Lilly Urinary System Drugs Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Tianjin Tongrentang Group

        • 14.15.1 Tianjin Tongrentang Group Company Profile

        • 14.15.2 Tianjin Tongrentang Group Urinary System Drugs Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Kunming Jida Pharmaceutical

        • 14.16.1 Kunming Jida Pharmaceutical Company Profile

        • 14.16.2 Kunming Jida Pharmaceutical Urinary System Drugs Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Bayer

        • 14.17.1 Bayer Company Profile

        • 14.17.2 Bayer Urinary System Drugs Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Mylan

        • 14.18.1 Mylan Company Profile

        • 14.18.2 Mylan Urinary System Drugs Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 GSK

        • 14.19.1 GSK Company Profile

        • 14.19.2 GSK Urinary System Drugs Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Jiangsu Hengrui Pharmaceutical

        • 14.20.1 Jiangsu Hengrui Pharmaceutical Company Profile

        • 14.20.2 Jiangsu Hengrui Pharmaceutical Urinary System Drugs Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Kowa

        • 14.21.1 Kowa Company Profile

        • 14.21.2 Kowa Urinary System Drugs Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Cubist Pharmaceuticals

        • 14.22.1 Cubist Pharmaceuticals Company Profile

        • 14.22.2 Cubist Pharmaceuticals Urinary System Drugs Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Dr Dunner

        • 14.23.1 Dr Dunner Company Profile

        • 14.23.2 Dr Dunner Urinary System Drugs Market Performance

        • 14.23.3 Product&Service Introduction

      • 14.24 Sanofi

        • 14.24.1 Sanofi Company Profile

        • 14.24.2 Sanofi Urinary System Drugs Market Performance

        • 14.24.3 Product&Service Introduction

      • 14.25 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical

        • 14.25.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Profile

        • 14.25.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Market Performance

        • 14.25.3 Product&Service Introduction

      • 14.26 Hunan Qianjin Xiang River Pharmaceutical

        • 14.26.1 Hunan Qianjin Xiang River Pharmaceutical Company Profile

        • 14.26.2 Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Market Performance

        • 14.26.3 Product&Service Introduction

      • 14.27 Melinta Therapeutics

        • 14.27.1 Melinta Therapeutics Company Profile

        • 14.27.2 Melinta Therapeutics Urinary System Drugs Market Performance

        • 14.27.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Urinary System Drugs Industry Research Conclusions

    • 15.2 Urinary System Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Urinary System Drugs Industry Market Size (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Powder (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Pills (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Cream (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Tablets (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Capsule (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Suppository (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Urinary System Drugs Production Volume, Production Value and Growth Rate of Granules (2018-2029)

    • Figure China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Medication For Prostate Disease (2018-2029)

    • Figure China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Male Dysfunction (2018-2029)

    • Figure China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Kidney Disease Medication (2018-2029)

    • Figure China Urinary System Drugs Sales Volume, Sales Value and Growth Rate of Lithotripsy Drug (2018-2029)

    • Figure North China Urinary System Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Urinary System Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Urinary System Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Urinary System Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Urinary System Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Urinary System Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Urinary System Drugs Market Size and Growth Rate from 2018-2029

    • Figure Urinary System Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Urinary System Drugs Market Share by Type in 2018

    • Figure China Urinary System Drugs Market Share by Type in 2023

    • Figure China Urinary System Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Powder (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Injection (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Pills (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Cream (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Tablets (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Capsule (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Suppository (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Urinary System Drugs Production Volume and Growth Rate of Granules (2018-2023)

    • Figure China Urinary System Drugs Market Share by Application in 2018

    • Figure China Urinary System Drugs Market Share by Application in 2023

    • Figure China Urinary System Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Urinary System Drugs Market Size and Growth Rate of Medication For Prostate Disease (2018-2023)

    • Figure China Urinary System Drugs Market Size and Growth Rate of Others (2018-2023)

    • Figure China Urinary System Drugs Market Size and Growth Rate of Male Dysfunction (2018-2023)

    • Figure China Urinary System Drugs Market Size and Growth Rate of Kidney Disease Medication (2018-2023)

    • Figure China Urinary System Drugs Market Size and Growth Rate of Lithotripsy Drug (2018-2023)

    • Table China Urinary System Drugs Production Volume by Region (2018-2023)

    • Table China Urinary System Drugs Production Volume Share by Region (2018-2023)

    • Figure China Urinary System Drugs Production Volume Share by Region (2018-2023)

    • Table China Urinary System Drugs Production Value by Region (2018-2023)

    • Table China Urinary System Drugs Production Value Share by Region (2018-2023)

    • Figure China Urinary System Drugs Production Value Share by Region (2018-2023)

    • Table China Urinary System Drugs Sales Volume by Region (2018-2023)

    • Table China Urinary System Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Urinary System Drugs Sales Volume Share by Region (2018-2023)

    • Table China Urinary System Drugs Sales Value by Region (2018-2023)

    • Table China Urinary System Drugs Sales Value Share by Region (2018-2023)

    • Figure China Urinary System Drugs Sales Value Share by Region (2018-2023)

    • Table North China Urinary System Drugs Production Volume by Type (2018-2023)

    • Table North China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Table North China Urinary System Drugs Sales Volume by Application (2018-2023)

    • Table North China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Urinary System Drugs Production Volume by Type (2018-2023)

    • Table Central China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Urinary System Drugs Sales Volume by Application (2018-2023)

    • Table Central China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Urinary System Drugs Production Volume by Type (2018-2023)

    • Table South China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Table South China Urinary System Drugs Sales Volume by Application (2018-2023)

    • Table South China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Urinary System Drugs Production Volume by Type (2018-2023)

    • Table East China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Table East China Urinary System Drugs Sales Volume by Application (2018-2023)

    • Table East China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Urinary System Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Urinary System Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Urinary System Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Urinary System Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Urinary System Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Urinary System Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Urinary System Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Urinary System Drugs Sales Volume Share by Application (2018-2023)

    • Table Lupin Company Profile

    • Table Lupin Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Cipla Company Profile

    • Table Cipla Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Apogepha Company Profile

    • Table Apogepha Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Jiangsu Lianhuan Pharmaceutical Company Profile

    • Table Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Sun Pharma Company Profile

    • Table Sun Pharma Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Company Profile

    • Table Daiichi Sankyo Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Tianjin Tongrentang Group Company Profile

    • Table Tianjin Tongrentang Group Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Kunming Jida Pharmaceutical Company Profile

    • Table Kunming Jida Pharmaceutical Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table GSK Company Profile

    • Table GSK Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Jiangsu Hengrui Pharmaceutical Company Profile

    • Table Jiangsu Hengrui Pharmaceutical Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Kowa Company Profile

    • Table Kowa Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Cubist Pharmaceuticals Company Profile

    • Table Cubist Pharmaceuticals Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Dr Dunner Company Profile

    • Table Dr Dunner Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Profile

    • Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Hunan Qianjin Xiang River Pharmaceutical Company Profile

    • Table Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Revenue, Price and Gross (2018-2023)

    • Table Melinta Therapeutics Company Profile

    • Table Melinta Therapeutics Urinary System Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US